Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2012. Start Trial.
Date Value
September 30, 2026 99.50%
August 31, 2026 99.50%
July 31, 2026 99.50%
June 30, 2026 99.50%
May 31, 2026 99.50%
April 30, 2026 99.50%
March 31, 2026 99.50%
February 28, 2026 99.50%
January 31, 2026 99.50%
December 31, 2025 99.50%
November 30, 2025 99.50%
October 31, 2025 99.50%
September 30, 2025 99.50%
August 31, 2025 99.50%
July 31, 2025 99.50%
June 30, 2025 99.50%
May 31, 2025 99.50%
April 30, 2025 99.50%
March 31, 2025 99.50%
February 28, 2025 99.50%
January 31, 2025 99.50%
December 31, 2024 99.50%
November 30, 2024 98.98%
October 31, 2024 98.31%
September 30, 2024 98.31%
Date Value
August 31, 2024 98.31%
July 31, 2024 98.31%
June 30, 2024 98.31%
May 31, 2024 98.31%
April 30, 2024 98.31%
March 31, 2024 98.31%
February 29, 2024 98.31%
January 31, 2024 98.31%
December 31, 2023 98.31%
November 30, 2023 98.31%
October 31, 2023 98.31%
September 30, 2023 98.31%
August 31, 2023 98.31%
July 31, 2023 98.31%
June 30, 2023 98.31%
May 31, 2023 98.31%
April 30, 2023 98.31%
March 31, 2023 98.44%
February 28, 2023 98.44%
January 31, 2023 98.58%
December 31, 2022 98.58%
November 30, 2022 98.58%
October 31, 2022 99.32%
September 30, 2022 99.32%
August 31, 2022 99.37%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Biotricity, Inc. 97.52%
Aclarion, Inc. --
HeartFlow, Inc. --
Agilent Technologies, Inc. 43.19%
Abbott Laboratories 39.63%